Dr. Mobley is considered an expert in proteomics by his peers, and as director of the Mass Spectrometry/Proteomics Shared Facility, continues to focus on clinical and translational proteomics applications, which include statistical analysis of high density 'omics driven data sets, and the use of systems biology applications to uncover biologically relevant pathways. He has nearly 30 years experience in academia and industry, and mass spectrometry has been a intricate part of his work experience and studies from the beginning.
Dr. Mobley obtained his B.S. in Chemistry at Oregon State University. He obtained a Ph.D. in Medicinal Chemistry and Pharmacology from The Ohio State University with an emphasis on hormonal induced carcinogesis. Prior to joining the faculty at UAB in 2006, Dr. Mobley worked as a faculty member at UMass Medical School and also at Vanderbilt.
In 2007, Dr. Mobley became Director of the newly formed UAB Comprehensive Cancer Center Clinical Proteomics Shared Facility, and due to the success of that facility he was asked to expand in 2009 to encompass a single campus wide MS/ Proteomics Shared Facility (MSP-SF).
Identification of disease-specific and clinically relevant markers of any disease/ disease process; application of high-level informatics to single and multiomics datasets for use in translational studies of disease